Skip to Content

Attana AB Ordinary Shares ATANA

Morningstar Rating
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

ATANA is trading within a range we consider fairly valued.
Price
SEK 0.07
Fair Value
SEK 3.90
Uncertainty
Extreme
1-Star Price
SEK 5.45
5-Star Price
SEK 8.82
Economic Moat
Pgsr
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ATANA is a good fit for your portfolio.

Trading Information

Previous Close Price
Day Range
52-Week Range
Bid/Ask
/
Market Cap
Volume/Avg
/

Key Statistics

Price/Earnings (Normalized)
Price/Sales
3.72
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Attana AB offers biologically relevant information to improve efficiency and performance of pharmaceutical drug development.
Sector
Healthcare
Industry
Diagnostics & Research
Stock Style Box
Small Value
Total Number of Employees
10

Valuation

Metric
ATANA
Price/Earnings (Normalized)
Price/Book Value
1.02
Price/Sales
3.72
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
ATANA
Quick Ratio
0.66
Current Ratio
0.94
Interest Coverage
−8.63
Quick Ratio
ATANA

Profitability

Metric
ATANA
Return on Assets (Normalized)
−45.80%
Return on Equity (Normalized)
−75.60%
Return on Invested Capital (Normalized)
−54.74%
Return on Assets
ATANA
See how this stock stacks up to its competitors with Morningstar Investor

Diagnostics & Research Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
TMO
Thermo Fisher Scientific IncMsgtdgfqdCxx$206.7 Bil
DHR
Danaher CorpKppswggmBlfglm$175.0 Bil
IQV
IQVIA Holdings IncFrspfmyHqqgfy$41.3 Bil
IDXX
IDEXX Laboratories IncPwhjxpqqyPlgzs$39.7 Bil
A
Agilent Technologies IncFywvklzbmSfc$38.8 Bil
MTD
Mettler-Toledo International IncLmdkgqjtGwrnxy$25.5 Bil
ICLR
Icon PLCBrzzdlsDqlxhl$24.1 Bil
ILMN
Illumina IncGvcjbhnWqnqkb$18.6 Bil
WAT
Waters CorpNcvhxwlmcKrn$18.0 Bil
LH
Laboratory Corp of America HoldingsPfpwvrnqrVkhfxsn$16.8 Bil

Sponsor Center